-
AI applications in pulmonary medicine: From training clinicians to transforming diagnostics and treatment
AI applications in health care are multiplying, and AI-focused research is gaining traction across specialties, including pulmonary, critical care, and sleep medicine.
Recent News
-
Top reads from the CHEST journal portfolio – December 2025
Read new research from the journal portfolio about IL-5-targeted biologic therapies, correct nasogastric tube placement, and the association of hypoxic burden with cardiovascular events.
-
Third trial supports sotatercept to treat PAH
Guidelines expert James R. Klinger, MD, FCCP, said that while the evidence of efficacy is clear, more research is needed to address questions regarding the optimal duration of therapy and the potential for disease progression if therapy is stopped.
-
Study demonstrates strong patient compliance with oral device for OSA
Evidence suggests that an oral device may be an effective alternative for patients who can’t access or tolerate CPAP therapy.
-
The climate cost of inhalers: What prescribers should know
Experts said clinicians must ensure patients have the therapies they need at affordable prices that, ideally, impose minimal amounts of environmental harm.
-
Update from the 2025 Council of Networks
Deborah Jo Levine, MD, MS, FCCP, Chair of Council of Networks, shares the highlights that made CHEST 2025 such a huge success for the community on the membership level.
-
Phase 3 IMPALA-2 clinical trial shows inhaled molgramostim promising for autoimmune pulmonary alveolar proteinosis
An ongoing 96-week, open-label period of the trial is designed to shed light on the drug’s long-term safety and efficacy.
